LIXT Archived Articles
Lixte Biotechnology Holdings, Inc. (LIXT): Pioneering Novel Cancer Therapies Through Strategic Collaborations
Published on March 14, 2025
Lixte Biotechnology (LIXT): Pioneering Novel Cancer Therapies to Enhance Chemotherapy and Immunotherapy
Published on November 28, 2024
Lixte Biotechnology Holdings, Inc. (LIXT): A Promising Protein Phosphatase 2A Inhibitor in Clinical Development
Published on September 24, 2024